Receive our newsletter – data, insights and analysis delivered to you
  1. News
September 8, 2020

IATF gives consent for recommendations on trials for Covid-19 vaccine

The Inter-agency Task Force (IATF) for the Management of Emerging Infectious Diseases organised by the executive of the Philippine Government has approved the recommendations for Covid-19 vaccine clinical trials.

The Inter-agency Task Force (IATF) for the Management of Emerging Infectious Diseases organised by the executive of the Philippine Government has approved the recommendations for Covid-19 vaccine clinical trials.

The approval on vaccine development was given in a resolution on the conduct of trials of the sub-technical working group (TWG) led by the Department of Science and Technology (DOST).

DOST Secretary Fortunato de la Peña, in a briefing with Presidential Spokesperson Harry Roque, said the sub-TWG was assisted by the Vaccine Expert Panel.

As per the recommendations, the World Health Organization (WHO) Solidarity Trial will be given priority in sites where clinical trials take place.

De la Peña said that the independent clinical trials will be conducted by companies, and the other one is the WHO Solidarity Trial.

The WHO will be prioritised in case of any competition in a trial site, but authorities will make sure the companies will not be deprived of the sites, De la Peña added.

Content from our partners
The importance of reference products in biosimilar trials, and how to source them
Africa’s last mile: Building viable vaccine supply chains
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success

Subjects for the WHO Solidarity Trial will be recruited from the top 5 to 10 barangays reporting high Covid-19 cases.

De la Peña further added: “Transient residents are discouraged unless they can prove they will stay there for another two years because we need to monitor them.”

The recommendations also state that trial zones will be assigned to independent trials to make sure there will be no competition in recruiting participants.

As agreed by the DOST and the Department of the Interior and Local Government (DILG), local government units (LGUs) will involve in the vaccine clinical trials.

Additionally, barangay volunteers and mobile phones will be used for follow-ups.

The IATF said that the DOH will be responsible for deciding the vaccine and the number of doses to be procured.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU